Evidence map›Paper›PMID 42599686›Full record

ArticleInternational forum of allergy & rhinology2026

Reply to: Malik MMUD on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).

Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, Claire Hopkins, Anju T Peters, Oliver Pfaar, Martin Desrosiers, Stella E Lee, Andrew P Lane, Claudia Chen and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in International forum of allergy & rhinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Joaquim MullolRhinology Unit & Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Catalonia, Spain.
Joseph K HanDepartment of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Tanya M LaidlawDivision of Allergy and Clinical Immunology, Department of Medicine, Jeff and Penny Vinik Center for Translational Immunology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Claire HopkinsDepartment of Otolaryngology-Head and Neck Surgery, Guy's and St Thomas' Hospital, London, UK.ORCID https://orcid.org/0000-0003-3993-1569
Anju T PetersDivision of Allergy and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-0745-2379
Oliver PfaarDepartment of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps University of Marburg, Marburg, Germany.
Martin DesrosiersDivision of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de L'université de Montréal, University of Montreal, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-3774-2959
Stella E LeeDivision of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-6563-6606
Andrew P LaneDepartment of Otolaryngology, Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-6369-5469
Claudia ChenBiometrics, Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
Yun ChonGlobal Biostatistical Science, Amgen, Thousand Oaks, California, USA.
Sandhia S PonnarambilRespiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Andrew FosterRespiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.
Andrew W LindsleyUS Medical Affairs, Amgen, Thousand Oaks, California, USA.
Christopher S AmbroseRespiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland, USA.ORCID https://orcid.org/0000-0003-4175-7336

Funding

Amgen IncAstraZeneca
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic rhinosinusitis with nasal polypssense of smelltezepelumab

Identifiers

PMID42599686
PMCPMC13544477

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.